These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26183704)

  • 1. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
    Patterson S; Cescon A; Samji H; Chan K; Zhang W; Raboud J; Burchell AN; Cooper C; Klein MB; Rourke SB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS;
    BMC Infect Dis; 2015 Jul; 15():274. PubMed ID: 26183704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.
    Samji H; Cescon A; Hogg RS; Modur SP; Althoff KN; Buchacz K; Burchell AN; Cohen M; Gebo KA; Gill MJ; Justice A; Kirk G; Klein MB; Korthuis PT; Martin J; Napravnik S; Rourke SB; Sterling TR; Silverberg MJ; Deeks S; Jacobson LP; Bosch RJ; Kitahata MM; Goedert JJ; Moore R; Gange SJ;
    PLoS One; 2013; 8(12):e81355. PubMed ID: 24367482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late initiation of combination antiretroviral therapy in Canada: a call for a national public health strategy to improve engagement in HIV care.
    Cescon A; Patterson S; Davey C; Ding E; Raboud JM; Chan K; Loutfy MR; Cooper C; Burchell AN; Palmer AK; Tsoukas C; Machouf N; Klein MB; Rourke SB; Rachlis A; Hogg RS; Montaner JS;
    J Int AIDS Soc; 2015; 18(1):20024. PubMed ID: 26443752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
    Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
    Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort study.
    Grimsrud A; Cornell M; Schomaker M; Fox MP; Orrell C; Prozesky H; Stinson K; Tanser F; Egger M; Myer L;
    J Epidemiol Community Health; 2016 Jun; 70(6):549-55. PubMed ID: 26700300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada.
    Lima VD; Eyawo O; Ma H; Lourenço L; Chau W; Hogg RS; Montaner JS
    J Int AIDS Soc; 2015; 18(1):20261. PubMed ID: 26449273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    Kerkhoff AD; Sikombe K; Eshun-Wilson I; Sikazwe I; Glidden DV; Pry JM; Somwe P; Beres LK; Simbeza S; Mwamba C; Bukankala C; Hantuba C; Moore CB; Holmes CB; Padian N; Geng EH
    PLoS Med; 2020 May; 17(5):e1003107. PubMed ID: 32401797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in all-cause and cause-specific mortality among HIV-infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001-2012.
    Cheung CC; Ding E; Sereda P; Yip B; Lourenco L; Barrios R; Montaner J; Hogg RS; Lima V; Moore DM
    HIV Med; 2016 Oct; 17(9):694-701. PubMed ID: 27279453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
    Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
    Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013.
    De La Mata NL; Ly PS; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Ross J; Law MG; Ng OT
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):555-562. PubMed ID: 28129256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
    May MT; Gompels M; Delpech V; Porter K; Orkin C; Kegg S; Hay P; Johnson M; Palfreeman A; Gilson R; Chadwick D; Martin F; Hill T; Walsh J; Post F; Fisher M; Ainsworth J; Jose S; Leen C; Nelson M; Anderson J; Sabin C;
    AIDS; 2014 May; 28(8):1193-202. PubMed ID: 24556869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of lost to follow-up in a "test and treat" programme among adult women with high-risk sexual behavior in Kampala, Uganda.
    Kamacooko O; Mayanja Y; Bagiire D; Namale G; Hansen CH; Seeley J
    BMC Public Health; 2020 Mar; 20(1):353. PubMed ID: 32183759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sex and age on outcomes among HIV-2-infected patients starting antiretroviral therapy in West Africa.
    Tchounga BK; Hønge BL; Eholie SP; Coffie PA; Jespersen S; Wejse C; Dabis F; Geoffrey GS; Ekouevi DK;
    AIDS; 2016 Nov; 30(17):2707-2714. PubMed ID: 27536979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.
    Hogg RS; Eyawo O; Collins AB; Zhang W; Jabbari S; Hull MW; Lima VD; Ahmed T; Kendall CE; Althoff KN; Justice AC; Barrios R; Shoveller J; Montaner JSG;
    Lancet HIV; 2017 Jun; 4(6):e270-e276. PubMed ID: 28262574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada.
    St-Jean M; Dong X; Tafessu H; Moore D; Honer WG; Vila-Rodriguez F; Sereda P; Hogg RS; Patterson TL; Salters K; Barrios R; Montaner JSG; Lima VD
    Int J Drug Policy; 2021 Oct; 96():103195. PubMed ID: 33773878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.
    Kalinjuma AV; Glass TR; Weisser M; Myeya SJ; Kasuga B; Kisung'a Y; Sikalengo G; Katende A; Battegay M; Vanobberghen F;
    J Int AIDS Soc; 2020 Mar; 23(3):e25460. PubMed ID: 32128998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.